Skip to content
Disclosery

Antipodean Advisors LLC

Follow

13F filer, CIK 1512566, New York, NY

Antipodean Advisors LLC reported $39,080,000 across 7 holdings for the quarter ended 2022-09-30, in a 13F-HR filed 2022-11-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000919574-22-006610

Period
2022-09-30
Reported value
$39.1M
Holdings
7
Top 10 weight
100%
New
0
Sold out
2

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
FXIexited-50,000-$1.7M
KWEBexited-50,000-$1.64M
GDXreduced-50,000-$1.21M
CVNAreduced-50,000-$1.02M
CDLXreduced-98,400-$925K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2022

Share positions as resolved from 13F-HR 0000919574-22-006610, largest first. % of portfolio is the value over $39,080,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
SESEA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: 350,000 shares; 2022Q1: 350,000 shares; 2022Q2: 350,000 shares; 2022Q3: 350,000 shares 350,000$19.6M50.2%0Timeline
CVNACARVANA COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: 405,000 shares; 2022Q1: 405,000 shares; 2022Q2: 405,000 shares; 2022Q3: 355,000 shares 355,000$7.21M18.44%-50,000Timeline
CDLXCARDLYTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: 638,800 shares; 2022Q1: 638,800 shares; 2022Q2: 638,800 shares; 2022Q3: 540,400 shares 540,400$5.08M13%-98,400Timeline
ATARA BIOTHERAPEUTICS INC C…ATARA BIOTHERAPEUTICS INC COM NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: 1,000,000 shares; 2022Q1: 1,000,000 shares; 2022Q2: 1,000,000 shares; 2022Q3: 1,000,000 shares 1,000,000$3.78M9.67%0
CAREMAX INCCAREMAX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: 600,000 shares; 2022Q1: 425,000 shares; 2022Q2: 425,000 shares; 2022Q3: 425,000 shares 425,000$3.01M7.71%0
GDXVANECK ETF TRUSTQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not reported; 2022Q1: not reported; 2022Q2: 60,000 shares; 2022Q3: 10,000 shares 10,000$241K0.62%-50,000Timeline
RSXVANECK RUSSIA ETFQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not reported; 2022Q1: 50,000 shares; 2022Q2: 50,000 shares; 2022Q3: 25,000 shares 25,000$141K0.36%-25,000Timeline

Sold out in Q3 2022

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
FXIISHARES TR50,000$1.7Mshares
KWEBKRANESHARES TRUST50,000$1.64Mshares

How Q3 2022 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000919574-22-006610 base2022-11-14acceptance time not in the bulk data set